自噬
生物发生
TFEB
化学
细胞生物学
脂滴
生物化学
溶酶体
突变体
调节器
过氧化物酶体
焊剂(冶金)
体内
KEAP1型
生物
皂甙
姜黄素
秀丽隐杆线虫
作者
Juan Bai,Zixian Zhu,Beibei Pan,Zihan Yang,Chengyu Dai,Shiting Huang,Ying Zhu,Yansheng Zhao,Na Zhang,Xiang Xiao
标识
DOI:10.1111/1750-3841.70923
摘要
Bitter melon saponin extract (BMSE) is well-known to exhibit anti-obesity activity. The network pharmacology study in our previous studies has confirmed that momordicine I was the core triterpenoid compound responsible for the lipid-lowering effects of BMSE, and lipophagy was predicted as the potential mechanism. However, the exact regulatory effects of momordicine I or BMSE on the whole autophagic flux and processes remained unknown. The present study aimed to investigate the specific molecular mechanisms of regulating lipophagy by momordicine I or BMSE in vivo and in vitro. Results demonstrated that both BMSE and momordicine I significantly alleviated lipid accumulation in HepG2 cells and C. elegans, with momordicine I showing a relatively superior effect. Furthermore, treatment with BMSE and momordicine I promoted the formation of autophagosomes, the autophagosomes-lysosome fusions, and autolysosome degradation in HepG2 cells, thereby enhancing autophagic flux. In addition, siRNA interferences and TFEB-deficient C. elegans mutants verified TFEB-mediated lysosomal biogenesis played an essential role in BMSE's effects on lipophagy. Moreover, molecular docking experiments further confirmed that momordicine I could combine TFEB's upstream regulators, AMPK/mTOR, thereby enhancing TFEB nuclear translocation. In summary, BMSE and momordicine I were able to activate the TFEB-mediated lysosomal biogenesis pathway to promote lipophagy and alleviate lipid accumulation.
科研通智能强力驱动
Strongly Powered by AbleSci AI